Press "Enter" to skip to content

New patent for Astellas drug XOSPATA

2
Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug XOSPATA

Annual Drug Patent Expirations for XOSPATA
Annual Drug Patent Expirations for XOSPATA

Xospata is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has thirty-three patent family members in twenty-six countries.

The generic ingredient in XOSPATA is gilteritinib fumarate. One supplier is listed for this compound. Additional details are available on the gilteritinib fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug XOSPATA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions